To register for updates about LYTGOBI® (futibatinib) tablets, please complete the following form:All fields are mandatory unless otherwise noted. Contact Information First Name Last Name Email Address State Select a State Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Guam Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming HCP Opt-In Check the box to receive additional product and clinical information from Taiho Oncology, Inc. and its affiliates, service providers, and co-promotion partners. You understand you may revoke your permission at any time by clicking on the link provided in the emails you’ll receive. To view our Privacy Policy please click here.